IL-17 signaling and A20, A balancing act

Cell Cycle

Volumn 12, Issue 22, 2013, Pages 3459-3460

  Garg, Abhishek V ^a   Gaffen, Sarah L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHASE PROMOTING COMPLEX; I KAPPA B KINASE GAMMA; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; MYELOID DIFFERENTIATION FACTOR 88; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PROTEIN A20; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UBIQUITIN CONJUGATING ENZYME 13; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; B CELL LYMPHOMA; CACHEXIA; EDITORIAL; GENE EXPRESSION; INFLAMMATION; NEGATIVE FEEDBACK; NONHUMAN; PHENOTYPE; PHYSICAL PHENOMENA; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STEADY STATE; TH17 CELL; TISSUE INJURY; UBIQUITINATION;

HUMANS; RECEPTORS, INTERLEUKIN-17; SIGNAL TRANSDUCTION; UBIQUITIN-SPECIFIC PROTEASES;

EID: 84890358285     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.26699     Document Type: Editorial

References (8)

1. Ma A, et al. Nat Rev Immunol 2012; 12:774-85; PMID:23059429;
2. Shembade N, et al. Cell Mol Immunol 2012; 9:123- 30; PMID:22343828;
3. Basak S, et al. Immunol Rev 2012; 246:221- 38; PMID:22435558;
4. Patel DD, et al. Ann Rheum Dis 2013; 72(Suppl 2):116-23;
5. Gaffen SL. Nat Rev Immunol 2009; 9:556-67; PMID:19575028;
6. Garg AV, et al. Sci Signal 2013; 6:ra44-55; PMID:23737552;
7. Ho AW, et al. PLoS One 2013; 8:e70168; PMID:23922952;
8. Maitra A, et al. Proc Natl Acad Sci U S A 2007; 104:7506-11; PMID:17456598; http://dx.doi.org/10.1073/pnas.0611589104